文献速递头颈外科

多变量风险评分改善HPV相关口咽鳞癌患者分层

Improvement of patient stratification in human papilloma virus-associated oropharyngeal squamous cell carcinoma by defining a multivariable risk score.
PubMed 文献 · Head Neck · 2021-08-01

基于UICC第8版分期、烟酒滥用、年龄和性别构建四组风险评分,与UICC第8版分期相比,该模型在风险分层间显示出更好分层的趋势。结论建议将年龄、性别、烟酒滥用加入现行UICC分期系统以改善HPV+口咽鳞癌的风险分层。

要点

  • 该风险模型在风险分层间(I/III、I/IV、II/IV,各p<0.002;I/II、II/III、III/IV,各p<0.09)显示更好分层趋势。
  • 建议将年龄、性别、烟酒滥用加入UICC分期系统以改善HPV+口咽鳞癌风险分层。

核心结论

  • 年龄、性别、烟酒滥用应加入现行UICC分期系统,以改善HPV+口咽鳞癌的风险分层。

研究设计与样本

  • 回顾性分析2002至2017年单中心526例口咽鳞癌病例,按UICC第7版和第8版分期分类。
  • 对HPV+口咽鳞癌基于多变量Cox回归分析临床和生活方式参数(UICC第8版分期、烟酒滥用、年龄、性别)计算四组简单风险评分。

主要发现

  • 与UICC第8版分期相比,所提风险模型在风险分层I/III、I/IV、II/IV间显示更好分层趋势(各p<0.002)。
  • 风险分层I/II、II/III、III/IV间亦显示更好分层趋势(各p<0.09)。

关键数值与推荐

  • 风险评分基于UICC第8版分期、烟酒滥用、年龄、性别四项参数构建四组风险分层。
  • 风险分层间比较:I/III、I/IV、II/IV各p<0.002;I/II、II/III、III/IV各p<0.09。

临床怎么用

  • 在HPV+口咽鳞癌患者中,可考虑结合年龄、性别、烟酒滥用与UICC第8版分期进行风险分层,以辅助筛选适合降强度治疗试验的患者。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Precise risk stratification models are necessary to determine patient selection for deintensifying treatment trials in human papilloma virus (HPV)-associated oropharyngeal squamous cell cancer (HPV+ OPSCC). METHODS: We examined 526 cases with OPSCC treated at our department between 2002 and 2017. Every patient was classified after the 7th and 8th edition UICC staging manual. For HPV+ OPSCC, we calculated a simple risk score with four risk groups based on multivariable Cox regression analysis of clinical and lifestyle parameters (UICC 8th edition stage, tobacco/alcohol abuse, age, gender). RESULTS: Two hundred and thirty-nine patients with OPSCC (45.4%) showed a positive histological HPV status. In comparison to UICC 8th edition stages, our proposed risk model showed a tendency for better stratification between risk strata I/III, I/IV, and II/IV (each p < 0.002) and I/II, II/III, and III/IV (each p < 0.09). CONCLUSION: Age, gender, tobacco, and alcohol abuse should be added to the current UICC staging system in order to improve risk stratification in HPV+ OPSCC.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Oberste M, Riders A, Abbaspour B, et al. Improvement of patient stratification in human papilloma virus-associated oropharyngeal squamous cell carcinoma by defining a multivariable risk score. Head Neck. 2021. PMID: 34337814. doi:10.1002/hed.26822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。